Innovation

State-backed ALX Oncology raises $63.2m in public offering

The Ireland Strategic Investment Fund (ISIF) has a minority interest in the Nasdaq-listed biotech company through its partnership with Lightstone Ventures

ALX is focused on helping patients fight cancer by developing a range of product candidates